Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

We present a thermal-driven, orthogonally polarized, eye-safe dual-wavelength microchip laser based on an cut Er,Yb:YAl(BO) (Er,Yb:YAB) crystal, operating without the need for additional intracavity elements. Two thermal management schemes were investigated, revealing that additional end-face cooling effectively reduces internal temperature gradients within the crystal. As a result, the laser achieved a total output power of 1.04 W at the polarization intersection point (PIP) and an extended polarization coexistence range (PCR) of up to 11 W, with dual-wavelength emission at 1551.9 nm and 1556.5 nm, corresponding to a frequency difference of 0.57 THz. Furthermore, by adjusting the cooling temperature, both the PIP output power and PCR exhibited an approximately linear dependence, offering a practical means of thermally controlling polarization dynamics. Theoretical simulations showed good agreement with experimental results, confirming the validity of the thermal-driving mechanism. This compact, alignment-free laser architecture holds strong potential for applications in laser interferometry, precision metrology, coherent THz radiation, and eye-safe differential absorption lidar.

Download full-text PDF

Source
http://dx.doi.org/10.1364/OE.565890DOI Listing

Publication Analysis

Top Keywords

thermal-driven orthogonally
8
orthogonally polarized
8
polarized eye-safe
8
eye-safe dual-wavelength
8
microchip laser
8
output power
8
laser
5
dual-wavelength erybyalbo
4
erybyalbo microchip
4
laser thermal-driven
4

Similar Publications

We present a thermal-driven, orthogonally polarized, eye-safe dual-wavelength microchip laser based on an cut Er,Yb:YAl(BO) (Er,Yb:YAB) crystal, operating without the need for additional intracavity elements. Two thermal management schemes were investigated, revealing that additional end-face cooling effectively reduces internal temperature gradients within the crystal. As a result, the laser achieved a total output power of 1.

View Article and Find Full Text PDF

Background: The commercial docetaxel (DTX) formulation causes severe side effects due to polysorbate 80 and ethanol. Novel surfactant-free nanoparticle (NP) systems are needed to improve bioavailability and reduce side effects. However, controlling the particle size and stability of NPs and improving the batch-to-batch variation are the major challenges.

View Article and Find Full Text PDF